Trodelvy, in combination with Merck Blockbuster immunotherapy, Keytruda reduced the risk of an aggressive type of breast cancer that worsened 35% when used as an initial treatment, according to the …
Hope is on the horizon for patients with aggressive and inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of a combination of …
Cancer diagnoses in people under the age of 50 are increasing. We are not exactly safe why, but we are seeing a particular blow to breast cancer, lymphoma and colorectal …